作者: Jean Costentin , Adina Vlaiculescu , Pierre Chaillet , Lucien Ben Natan , Dominique Aveaux
DOI: 10.1016/0014-2999(86)90684-9
关键词: Receptor antagonist 、 Endocrinology 、 Pharmacology 、 Opiate 、 Enkephalinase 、 (+)-Naloxone 、 Thiorphan 、 Enkephalin 、 Internal medicine 、 Opioid peptide 、 Morphine 、 Chemistry
摘要: Abstract The antinociceptive effects of Thiorphan, an ‘enkephalinase’ inhibitor, or bestatin, aminopeptidase inhibitor as well their association and the pronociceptive naloxone, opiate receptor antagonist, were evaluated iin various analgesic tests in mice. These could be classified into two groups: (i) those which peptidase inhibitors display naloxone-sensitive activity, particularly when administered together, naloxone displays activity (vocalisation, hot-plate jump, writhing), (ii) are ineffective (tail withdrawal, licking, tail-flick). In contrast to above, either morphine [Met 5 ]enkephalin subthreshold dosage together with displayed groups tests. threshold dosages lowest first group. dissociated opposite per se might reflect a variable participation endogenous enkephalins (or other opioid peptides) control nociceptive responses.